Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech Surpasses Q4 Revenue Estimates

TheMotleyFool 
0 0 10.03.25
BioNTech Surpasses Q4 Revenue Estimates
 

Biopharmaceutical company BioNTech SE (NASDAQ:BNTX) reported fourth-quarter and full-year 2024 earnings on Monday, March 10, that topped analysts' consensus expectations. It reported revenue of 1.19 billion euros, ahead of estimates for 1.14 billion but down nearly 43% from the prior year's quarter. Earnings per share (EPS) stood at 1.08 euros against the expected 0.42 euros, a significant outperformance.

This quarter displayed resilience, focusing on R expansion, primarily in oncology, while navigating reduced COVID-19 vaccine demand and legal challenges.

Source: BioNTech. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year.

Continue reading


Source Fool.com

Electro Power Systems S.A. Stock

Show more
Like: 0
BNTX
Share

Comments

Not a member yet? Sign up for free!